Mits Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-01-2025
- Paid Up Capital ₹ 0.10 M
as on 03-01-2025
- Company Age 11 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.20 M
as on 03-01-2025
- Revenue 55.64%
(FY 2022)
- Profit 252.28%
(FY 2022)
- Ebitda 166.25%
(FY 2022)
- Net Worth 58.16%
(FY 2022)
- Total Assets 5.14%
(FY 2022)
About Mits Nutraceuticals
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.20 M.
Vivek Diwedi, Vinodkumar Tiwari, Mohammed Patel, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24233MH2013PTC247080
- Company No.
247080
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Aug 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Mits Nutraceuticals?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Diwedi  | Director | 16-Aug-2013 | Current |
| Mohammed Patel | Director | 08-Dec-2014 | Current |
| Vinodkumar Tiwari | Director | 16-Aug-2013 | Current |
| Nitu Diwedi | Director | 01-Mar-2022 | Current |
| Mariam Patel | Director | 01-Mar-2022 | Current |
| Seema Tiwari | Director | 01-Mar-2022 | Current |
Financial Performance of Mits Nutraceuticals.
Mits Nutraceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 55.64% increase. The company also saw a substantial improvement in profitability, with a 252.28% increase in profit. The company's net worth Soared by an impressive increase of 58.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mits Nutraceuticals?
In 2021, Mits Nutraceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Jun 2024 | ₹3.40 M | Open |
Hdfc Bank Limited Creation Date: 20 Aug 2019 | ₹2.80 M | Open |
How Many Employees Work at Mits Nutraceuticals?
Unlock and access historical data on people associated with Mits Nutraceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mits Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mits Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
